CD4 and lung cancer: Putatively terminally-differentiated CD4 + EMRA and CD8 + EMRA T cells decreased after BT treatment, whereas CD4 + naïve T cells increased also in patients with advanced lung cancer, immediately after platinum-based chemotherapy.